Header Logo

Meenakshi Jolly

Concepts (302)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Erythematosus, Systemic
77
2023
173
21.510
Why?
Quality of Life
41
2023
606
7.960
Why?
Surveys and Questionnaires
22
2023
1034
3.030
Why?
Severity of Illness Index
28
2020
853
2.580
Why?
Health Status
11
2018
171
2.510
Why?
Patient Reported Outcome Measures
11
2021
493
2.310
Why?
Psychometrics
16
2022
232
2.290
Why?
Rheumatology
6
2019
45
2.000
Why?
Adult
55
2022
7516
1.970
Why?
Body Image
6
2017
25
1.890
Why?
Self Report
8
2023
197
1.770
Why?
Female
66
2022
14520
1.760
Why?
Middle Aged
48
2021
8541
1.740
Why?
Humans
86
2023
26260
1.660
Why?
Reproducibility of Results
20
2022
683
1.470
Why?
Cross-Cultural Comparison
9
2022
37
1.430
Why?
Patient Outcome Assessment
3
2015
36
1.380
Why?
Male
49
2022
14168
1.350
Why?
Hydroxychloroquine
3
2021
10
1.320
Why?
Antirheumatic Agents
3
2021
38
1.290
Why?
Lupus Erythematosus, Discoid
3
2021
6
1.240
Why?
Rheumatologists
2
2018
12
1.180
Why?
Pain
7
2020
380
1.020
Why?
Cross-Sectional Studies
14
2021
875
1.010
Why?
Fatigue
4
2020
60
0.920
Why?
Health Status Indicators
3
2014
41
0.910
Why?
Lupus Erythematosus, Cutaneous
2
2014
5
0.890
Why?
Interferon-alpha
7
2014
32
0.790
Why?
Depression
4
2020
400
0.780
Why?
Pneumococcal Infections
1
2021
6
0.770
Why?
Quality of Health Care
3
2023
115
0.750
Why?
Pain Measurement
5
2019
418
0.730
Why?
Antibodies, Antinuclear
5
2018
11
0.720
Why?
Sickness Impact Profile
4
2014
12
0.710
Why?
Lupus Nephritis
2
2017
31
0.620
Why?
Outpatient Clinics, Hospital
1
2018
14
0.620
Why?
Delivery of Health Care, Integrated
1
2018
23
0.610
Why?
Quality Indicators, Health Care
1
2018
35
0.610
Why?
Academic Medical Centers
1
2019
124
0.590
Why?
Young Adult
12
2020
1948
0.580
Why?
Cost of Illness
2
2015
41
0.580
Why?
Sleep Wake Disorders
1
2019
121
0.570
Why?
Factor Analysis, Statistical
7
2020
61
0.570
Why?
Unnecessary Procedures
1
2017
26
0.550
Why?
Physicians
3
2015
105
0.540
Why?
Arthritis, Rheumatoid
4
2019
138
0.540
Why?
Adolescent
11
2020
2172
0.540
Why?
Culture
2
2013
26
0.530
Why?
Tattooing
2
2007
3
0.530
Why?
Practice Patterns, Physicians'
1
2017
112
0.520
Why?
Canada
4
2018
49
0.510
Why?
Language
6
2022
65
0.500
Why?
Biological Products
1
2016
38
0.500
Why?
Linear Models
6
2018
238
0.480
Why?
United States
7
2018
2043
0.460
Why?
Immunoglobulin kappa-Chains
1
2014
2
0.460
Why?
Immunoglobulin lambda-Chains
1
2014
2
0.460
Why?
Interleukin-10
1
2014
20
0.450
Why?
Interleukin-6
1
2014
73
0.450
Why?
Autoantibodies
8
2013
78
0.440
Why?
Treatment Outcome
10
2018
3285
0.440
Why?
Patient Education as Topic
1
2014
141
0.430
Why?
Posterior Leukoencephalopathy Syndrome
1
2013
9
0.430
Why?
Caregivers
1
2015
119
0.430
Why?
Teaching
2
2019
57
0.420
Why?
Cultural Characteristics
1
2013
21
0.420
Why?
Dermatology
1
2012
5
0.410
Why?
Diagnostic Self Evaluation
1
2012
12
0.410
Why?
Longitudinal Studies
6
2020
1295
0.410
Why?
Hospitals, County
1
2012
3
0.410
Why?
Hospitals, University
1
2012
27
0.400
Why?
Adaptation, Psychological
5
2016
154
0.400
Why?
Polymorphism, Single Nucleotide
8
2017
272
0.390
Why?
Body Dysmorphic Disorders
1
2011
2
0.390
Why?
Emotions
3
2017
70
0.390
Why?
Immunoglobulin Light Chains
1
2011
6
0.370
Why?
Aged
10
2021
8595
0.370
Why?
Genetic Predisposition to Disease
6
2018
380
0.350
Why?
Benchmarking
1
2010
35
0.340
Why?
Demography
1
2010
67
0.340
Why?
Cognitive Dysfunction
1
2019
989
0.340
Why?
Income
1
2010
73
0.330
Why?
Clinical Trials as Topic
4
2016
211
0.330
Why?
Predictive Value of Tests
4
2017
422
0.320
Why?
Activities of Daily Living
2
2012
571
0.310
Why?
Stress, Psychological
3
2020
218
0.310
Why?
Case-Control Studies
6
2014
567
0.310
Why?
Randomized Controlled Trials as Topic
3
2016
303
0.300
Why?
Paracentesis
1
2007
4
0.280
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2007
1
0.280
Why?
Suction
1
2007
39
0.280
Why?
Genital Diseases, Female
1
2006
5
0.270
Why?
Reference Values
3
2014
189
0.270
Why?
Chronic Disease
2
2005
413
0.270
Why?
Hyperuricemia
1
2006
3
0.260
Why?
Chicago
2
2018
857
0.250
Why?
Takayasu Arteritis
1
2005
1
0.250
Why?
Uveitis
1
2005
10
0.250
Why?
Metabolic Syndrome
1
2006
60
0.250
Why?
Leukoencephalopathy, Progressive Multifocal
1
2007
113
0.250
Why?
Vasculitis
1
2005
25
0.240
Why?
Prognosis
3
2014
710
0.240
Why?
Pre-Eclampsia
1
2004
6
0.240
Why?
Heart Diseases
1
2005
62
0.230
Why?
Tumor Necrosis Factor-alpha
1
2005
180
0.230
Why?
Chlamydia trachomatis
1
2004
6
0.230
Why?
Antibodies, Monoclonal
1
2005
189
0.230
Why?
Chlamydia Infections
1
2004
7
0.230
Why?
Pregnancy Complications
1
2004
46
0.220
Why?
Depressive Disorder
2
2018
175
0.220
Why?
Translations
2
2013
12
0.220
Why?
Diagnosis, Differential
3
2013
343
0.210
Why?
Comorbidity
3
2013
468
0.210
Why?
Cardiovascular Diseases
1
2006
338
0.200
Why?
Patient Acceptance of Health Care
1
2023
74
0.200
Why?
Sex Factors
2
2018
456
0.200
Why?
Vaccination
1
2021
29
0.190
Why?
Immunocompromised Host
1
2021
43
0.190
Why?
Prospective Studies
3
2020
1665
0.190
Why?
Regression Analysis
3
2020
249
0.180
Why?
Autoimmunity
2
2010
12
0.170
Why?
Health Surveys
2
2017
81
0.170
Why?
Cohort Studies
6
2017
1801
0.170
Why?
Databases, Factual
1
2021
315
0.170
Why?
Multivariate Analysis
2
2018
296
0.170
Why?
Age Factors
3
2016
744
0.160
Why?
Azacitidine
1
2019
10
0.160
Why?
Asia
1
2018
9
0.160
Why?
Enzyme Inhibitors
1
2019
114
0.160
Why?
Europe
1
2018
57
0.160
Why?
Appointments and Schedules
1
2018
13
0.160
Why?
Morbidity
1
2018
49
0.160
Why?
Mentors
1
2019
39
0.160
Why?
Arthritis, Experimental
1
2019
48
0.160
Why?
Sex Distribution
1
2018
77
0.150
Why?
Patient Acuity
1
2018
7
0.150
Why?
Workload
1
2018
30
0.150
Why?
Phenotype
4
2012
305
0.150
Why?
Faculty, Medical
1
2019
41
0.150
Why?
Risk Assessment
2
2014
592
0.150
Why?
Biomedical Research
1
2019
58
0.150
Why?
Pilot Projects
2
2020
397
0.150
Why?
Psychiatric Status Rating Scales
1
2018
312
0.140
Why?
DNA Methylation
1
2019
161
0.140
Why?
Interferon Type I
2
2017
10
0.140
Why?
Genome-Wide Association Study
4
2012
275
0.140
Why?
Blood Sedimentation
1
2017
44
0.140
Why?
Retrospective Studies
2
2018
3283
0.140
Why?
Philippines
2
2017
4
0.140
Why?
Health Care Surveys
1
2017
64
0.140
Why?
CD11b Antigen
1
2017
13
0.140
Why?
Toll-Like Receptors
1
2017
15
0.140
Why?
Illinois
1
2017
223
0.130
Why?
Socioeconomic Factors
3
2016
279
0.130
Why?
Macrophages
1
2017
101
0.130
Why?
Time Factors
2
2017
1347
0.130
Why?
Health Status Disparities
1
2017
68
0.130
Why?
France
1
2016
16
0.130
Why?
Mental Health
1
2017
113
0.130
Why?
Sleep Initiation and Maintenance Disorders
1
2017
104
0.130
Why?
Arthralgia
2
2008
123
0.130
Why?
Magnetic Resonance Imaging
2
2013
1069
0.120
Why?
Hong Kong
1
2015
2
0.120
Why?
Software
1
2015
63
0.120
Why?
Interferon Regulatory Factor-7
2
2017
4
0.120
Why?
Self Concept
2
2012
41
0.120
Why?
Professional-Patient Relations
1
2015
23
0.120
Why?
Cosmetic Techniques
1
2014
5
0.120
Why?
Double-Blind Method
1
2016
411
0.120
Why?
Observational Studies as Topic
1
2014
16
0.120
Why?
Critical Pathways
1
2014
17
0.120
Why?
Dose-Response Relationship, Drug
1
2015
330
0.120
Why?
Sleep
1
2017
314
0.120
Why?
Chi-Square Distribution
1
2014
131
0.120
Why?
Focus Groups
1
2014
85
0.110
Why?
Goals
1
2014
38
0.110
Why?
Combined Modality Therapy
1
2014
294
0.110
Why?
Genetic Variation
2
2011
96
0.110
Why?
Interferon Regulatory Factors
1
2013
2
0.110
Why?
Turkey
1
2013
6
0.110
Why?
Promoter Regions, Genetic
2
2011
93
0.110
Why?
Latin America
1
2013
5
0.110
Why?
Disease Management
1
2013
104
0.100
Why?
Self-Assessment
1
2012
24
0.100
Why?
Matched-Pair Analysis
1
2012
30
0.100
Why?
Multiple Sclerosis
1
2013
98
0.100
Why?
Quality Improvement
1
2013
140
0.100
Why?
Feedback
1
2012
28
0.100
Why?
Osteopontin
1
2011
5
0.100
Why?
Ubiquitin-Conjugating Enzymes
1
2011
5
0.100
Why?
Sensitivity and Specificity
1
2013
473
0.100
Why?
Gene Expression Profiling
1
2012
136
0.100
Why?
Aged, 80 and over
2
2019
4594
0.090
Why?
DEAD-box RNA Helicases
1
2011
5
0.090
Why?
Complementary Therapies
1
2011
8
0.090
Why?
DNA
4
2013
104
0.090
Why?
Genetic Association Studies
1
2011
81
0.090
Why?
Alleles
4
2011
206
0.090
Why?
Class III Phosphatidylinositol 3-Kinases
1
2010
1
0.090
Why?
Models, Genetic
1
2010
39
0.090
Why?
Epitopes
1
2010
48
0.090
Why?
Phosphatidylinositol 3-Kinases
1
2010
38
0.090
Why?
Disease Models, Animal
2
2019
600
0.090
Why?
Intracellular Signaling Peptides and Proteins
1
2010
51
0.080
Why?
United Kingdom
1
2010
48
0.080
Why?
Follow-Up Studies
1
2014
1722
0.080
Why?
Nuclear Proteins
1
2010
86
0.080
Why?
Social Environment
1
2010
76
0.080
Why?
Animals
3
2019
3551
0.080
Why?
Self-Examination
1
2009
3
0.080
Why?
California
3
2017
27
0.080
Why?
Cytokines
1
2010
224
0.080
Why?
Educational Status
1
2010
283
0.080
Why?
Biomarkers
1
2011
556
0.080
Why?
Analgesics, Non-Narcotic
1
2008
16
0.070
Why?
Prevalence
2
2011
441
0.070
Why?
Patient Satisfaction
1
2010
314
0.070
Why?
Therapeutic Irrigation
1
2007
54
0.070
Why?
Fatal Outcome
1
2007
56
0.070
Why?
Joints
1
2007
51
0.070
Why?
Vulva
1
2006
2
0.070
Why?
Data Collection
1
2007
88
0.070
Why?
Injections, Intra-Articular
1
2007
90
0.070
Why?
Education, Medical, Undergraduate
1
2007
36
0.070
Why?
Skin Diseases
1
2006
18
0.070
Why?
Disability Evaluation
2
2020
234
0.070
Why?
Cognition
1
2014
1276
0.070
Why?
Infliximab
1
2005
12
0.060
Why?
Hepatitis B
1
2005
12
0.060
Why?
Probability
1
2005
86
0.060
Why?
Genotype
3
2011
350
0.060
Why?
Autoimmune Diseases
2
2019
48
0.060
Why?
Pregnancy Outcome
1
2004
17
0.060
Why?
Sulfasalazine
1
2004
3
0.060
Why?
Lactones
1
2004
9
0.060
Why?
Myocardial Infarction
1
2005
122
0.060
Why?
Methotrexate
1
2004
20
0.060
Why?
Sulfones
1
2004
20
0.060
Why?
Doxycycline
1
2004
15
0.060
Why?
Drug Therapy, Combination
1
2004
169
0.060
Why?
Internship and Residency
1
2007
201
0.060
Why?
Mice
2
2019
1380
0.060
Why?
Synovial Fluid
1
2004
95
0.050
Why?
Pregnancy
1
2004
312
0.050
Why?
Osteoarthritis, Knee
1
2008
361
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2004
108
0.050
Why?
Prostaglandins A
1
2022
1
0.050
Why?
Republic of Korea
1
2022
5
0.050
Why?
Hypertension
1
2004
230
0.050
Why?
Ribonucleoproteins
2
2011
3
0.050
Why?
Anti-Bacterial Agents
1
2004
362
0.050
Why?
Cell Line
2
2012
262
0.050
Why?
Egypt
1
2020
2
0.040
Why?
Polymorphism, Genetic
2
2011
62
0.040
Why?
Chromatin Immunoprecipitation
1
2019
21
0.040
Why?
Gene Silencing
1
2019
23
0.040
Why?
Anxiety
1
2020
149
0.040
Why?
B-Lymphocytes
1
2019
51
0.040
Why?
Flow Cytometry
1
2019
114
0.040
Why?
Malaria
1
2018
4
0.040
Why?
Immunoglobulin M
1
2018
16
0.040
Why?
Complement C1q
1
2018
7
0.040
Why?
Glucocorticoids
1
2018
58
0.040
Why?
Immunoglobulin G
1
2018
92
0.040
Why?
Georgia
1
2017
10
0.040
Why?
Southeastern United States
1
2017
13
0.040
Why?
Mice, Inbred MRL lpr
1
2017
2
0.040
Why?
Interferon Regulatory Factor-3
1
2017
2
0.040
Why?
Forkhead Box Protein O3
1
2017
5
0.030
Why?
Japan
1
2016
5
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2017
40
0.030
Why?
Social Class
1
2017
59
0.030
Why?
Australia
1
2016
40
0.030
Why?
Registries
1
2017
170
0.030
Why?
Child
1
2020
1326
0.030
Why?
Disabled Persons
1
2016
122
0.030
Why?
Risk Factors
2
2011
2221
0.030
Why?
3' Untranslated Regions
1
2011
5
0.020
Why?
Anemia, Hemolytic
1
2011
3
0.020
Why?
Autoantigens
1
2011
25
0.020
Why?
Thrombocytopenia
1
2011
19
0.020
Why?
Interferon-Induced Helicase, IFIH1
1
2011
1
0.020
Why?
Mexican Americans
1
2011
28
0.020
Why?
Receptors, Lysophosphatidic Acid
1
2010
1
0.020
Why?
Databases, Genetic
1
2010
8
0.020
Why?
Principal Component Analysis
1
2010
25
0.020
Why?
Antibody Specificity
1
2010
35
0.020
Why?
Aminopeptidases
1
2010
7
0.020
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2010
1
0.020
Why?
Protein Structure, Quaternary
1
2010
5
0.020
Why?
Immunoprecipitation
1
2010
24
0.020
Why?
Immunoblotting
1
2010
53
0.020
Why?
Genetic Loci
1
2010
48
0.020
Why?
Transfection
1
2010
111
0.020
Why?
Interferon-gamma
1
2010
82
0.020
Why?
Gene Frequency
1
2010
60
0.020
Why?
Polymerase Chain Reaction
1
2010
116
0.020
Why?
Signal Transduction
1
2011
417
0.020
Why?
Gene Expression Regulation
1
2010
269
0.020
Why?
DNA-Binding Proteins
1
2010
262
0.020
Why?
Algorithms
1
2010
357
0.020
Why?
Knee Joint
1
2008
740
0.010
Why?
Jolly's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (302)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_